Zentalis Pharmaceuticals Llc
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -157 | -160 | -262 | |
EBITDA | -37,236 | -26,531 | -34,746 | -37,565 |
EBIT | -37,393 | -26,691 | -34,906 | -37,827 |
Net Income | -35,216 | -26,691 | -26,874 | -48,279 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -30,940 | -26,963 | -34,708 | -32,636 |
Cash | 35,995 | 39,072 | 37,599 | 41,929 |
Basic Shares | 71,670 | 72,139 | 71,992 | 71,678 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $67,425 | $0 | $0 |
Gross Profit | -739 | 67,425 | -1,389 | -1,426 |
EBITDA | -145,512 | -186,169 | -247,599 | -225,861 |
EBIT | -146,251 | -187,458 | -248,988 | -227,287 |
Net Income | -137,060 | -165,839 | -292,191 | -236,806 |
Net Change In Cash | 0 | 67,425 | 0 | 0 |
Cost of Revenue | -16,888 | |||
Free Cash Flow | -125,247 | -171,081 | -208,405 | -166,299 |
Cash | 35,995 | 33,901 | 28,038 | 43,069 |
Basic Shares | 71,869 | 71,080 | 65,409 | 52,857 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.49 |
2025-09-30 | -$0.37 |
2025-06-30 | -$0.37 |
